Serum biomarker panel may help predict Crohn’s diagnosis

A panel of serum antibodies and proteins helped identify patients who later received a diagnosis of Crohn’s disease within 5 years, according to research published in Gastroenterology.Jean-Frederic Colombel, MD, PhD, of the Icahn School of Medicine at Mount Sinai, and colleagues wrote that inflammatory bowel disease appears to be like other immune-mediated diseases, in that it is proceeded by an asymptomatic, pre-clinical period.“Gaining insight into this phase could allow disease prediction,” they wrote. “The PREDICTS (Proteomic Evaluation and Discovery in an IBDRead More

Share on facebook
Share on twitter
Share on linkedin